Regulatory Manufacturing CDMO with decades of experience in formulation, manufacturing, and packaging of OTC and consumer health products. Capabilities include non sterile liquids and semi solids such as syrups, suspensions, creams, ointments, and gels, as well as solid dose tablets and capsules, plus integrated manufacturing and packaging. The Brockville facility is cGMP compliant and aligned with FDA and Health Canada requirements to support cross border commercialization in North America. This enables efficient scale up from development to commercial production and reduces regulatory risk for customers.

Cross Border Advantage Strategically located Brockville facility supports efficient cross border distribution between Canada and the U.S., with capabilities to manage scale up, regulatory documentation, packaging compatibility, and supply chain reliability—key for brands pursuing consistent North American launches.

Growth Backing The group was acquired by Avista Healthcare Partners, signaling potential access to additional capital and strategic resources that can back capacity expansion, portfolio synergies, and faster commercialization for consumer health brands.

Trusted Partner As a trusted partner to leading North American brands, Trillium offers end to end support from development to commercial production, with a track record of addressing scale up, packaging compatibility, regulatory documentation, and supply chain reliability.

Expansion Opportunities Growth opportunities exist to broaden service offerings, including expanded dosage forms, packaging innovations, and enhanced regulatory documentation support, leveraging regulatory expertise and integrated manufacturing to attract brands seeking speed to market and reliable supply.